Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma.
Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma.
复制标题
膜联蛋白 A3 上调浸润性中性粒细胞-淋巴细胞比率,重塑肝细胞癌的免疫微环境。
DOI:
10.1016/j.intimp.2020.107139
复制
发表时间:
2020-11
影响因子:
5.6
通讯作者:
Xia Jian-Chuan
中科院分区:
文献类型:
--
作者:
Zhu Qian;Pan Qiu-Zhong;Zhong Ai-Lin;Hu Hao;Zhao Jing-Jing;Tang Yan;Hu Wan-Ming;Li Min;Weng De-Sheng;Chen Ming-Yuan;Ma Gang;Xia Jian-Chuan
Accumulating evidence has indicated that inflammation is required for the initiation and progression of hepatocellular carcinoma (HCC). The annexin family protein, which has a highly similar structure, has been demonstrated to participate in pro- or anti-inflammatory regulation in the developing of tumours. However, the potential effects of ANXA3 in the immune microenvironment of HCC remain unknown. In present study, we found that increased ANXA3 expression is associated with a higher infiltrated neutrophil-lymphocyte ratio (iNLR) in HCC. Moreover, HCC patients with a high iNLR and high ANXA3 expression confer the highest risk of death. ANXA3 can be detected in both cell lysates and culture supernatants. However, the secretory ANXA3 did not directly regulate the iNLR. Further study demonstrated that ANXA3 upregulated the iNLR by inducing chemokine CXCL8 and CCL25 release from HCC cells. We further confirmed that ANXA3 promotes tumourigenesis and detected the same associations between ANXA3 and the iNLR or chemokinesin vivo. Our findings indicate that ANXA3 regulates the chemokine to remodel the iNLR and promotes tumourigenicity in HCC. These results further expanded our understanding of ANXA3 in the microenvironment of HCC and might provide novel targets for the investigation of molecular treatments for HCC patients.
登录
查看更多内容
DOI:
10.1002/mc.22697
发表时间:
2017
期刊:
Mol Carcinog
影响因子:
--
作者:
Zhang Xiao-Fei;Weng De-Sheng;Pan Ke;Zhou Zi-Qi;Pan Qiu-Zhong;Zhao Jing-Jing;Tang Yan;Jiang Shan-Shan;Chen Chang-Long;Li Yong-Qiang;Zhang Hong-Xia;Chang Alfred E;Wicha Max S;Zeng Yi-Xin;Li Qiao;Xia Jian-Chuan
通讯作者:
Xia Jian-Chuan
DOI:
10.1007/s13277-015-4148-x
发表时间:
2016-03
期刊:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
影响因子:
--
作者:
Zhu Q;Cao SM;Lin HX;Yang Q;Liu SL;Guo L
通讯作者:
Guo L
影响因子:
3
作者:
R. Pang;R. Poon
通讯作者:
R. Pang;R. Poon
影响因子:
6.4
作者:
Matsuo, Yoichi;Ochi, Nobuo;Sawai, Hirozumi;Yasuda, Akira;Takahashi, Hiroki;Fumahashi, Hitoshi;Takeyama, Hiromitsu;Tong, Zhimin;Guha, Sushovan
通讯作者:
Guha, Sushovan
DOI:
--
发表时间:
1998
期刊:
The American journal of pathology
影响因子:
--
作者:
Y. Kitadai;K. Haruma;K. Sumii;Soichiro Yamamoto;T. Ue;H. Yokozaki;Wataru Yasui;Yasukazu Ohmoto;G. Kajiyama;I. J. Fidler;Eiichi Tahara
通讯作者:
Y. Kitadai;K. Haruma;K. Sumii;Soichiro Yamamoto;T. Ue;H. Yokozaki;Wataru Yasui;Yasukazu Ohmoto;G. Kajiyama;I. J. Fidler;Eiichi Tahara